Clincosm LogoSign in Get a demo

dyslipidemia

Showing 26 - 50 of 348
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dual Inhibition Lipid-lowering in Treatment of

Completed
  • Dyslipidemia
  • Ezetimibe 10 mg plus statin or ezetimibe 10 mg plus fenofibrate
  • (no location specified)
Feb 7, 2022

Dyslipidemia, Hypercholesterolemia Trial in Seoul (Test Meal)

Completed
Has Results
  • Dyslipidemia
  • Hypercholesterolemia
  • Test Meal
  • Seoul, Korea, Republic of
    MSD Korea Ltd.
Feb 7, 2022

Lipid Control in Hyperlipidemic Participants (MK-0653-179)

Completed
Has Results
  • Dyslipidemia
  • (no location specified)
Feb 7, 2022

Therapeutic Effectiveness and Safety of Olomax Tab

Enrolling by invitation
  • Hypertension
  • Dyslipidemia
  • Olmesartan Medoxomil
  • Hwaseong-si, Gyeonggi, Korea, Republic of
    Hallym University Dongtan Sacred Heart Hospital
Dec 21, 2021

Dyslipidemia Trial in United States (K-877-ER (Dose A), K-877-ER (Dose B), K-877-IR)

Completed
  • Dyslipidemia
  • K-877-ER (Dose A)
  • +2 more
  • Anniston, Alabama
  • +11 more
Dec 1, 2021

Low-Density Lipoprotein Cholesterol and Dyslipidemia

Completed
  • Medical Conditions to be Studied
  • +2 more
    • Chandler, Arizona
    • +117 more
    Sep 1, 2021

    Dyslipidemia Trial in Davis (Krill Oil, Lutein, Nicotinic acid)

    Active, not recruiting
    • Dyslipidemia
    • Krill Oil
    • +4 more
    • Davis, California
      UC Davis, Ragle Human Nutrition Center
    Aug 9, 2021

    Dyslipidemia, Atherosclerosis Trial in Wenzhou (Red yeast rice and atorvastatin, Atorvastatin alone)

    Recruiting
    • Dyslipidemia
    • Atherosclerosis
    • Red yeast rice and atorvastatin
    • Atorvastatin alone
    • Wenzhou, Zhejiang, China
      The Second Hispital of Wenzhou Medical University
    Jul 19, 2021

    Dyslipidemia, Obesity Trial in Davis (Chardonnay grape marc marc high polyphenol dose (120mg), Chardonnay grape marc powder low

    Completed
    • Dyslipidemia
    • Obesity
    • Chardonnay grape marc marc high polyphenol dose (120mg)
    • +2 more
    • Davis, California
      Western Human Nutrition Research Center
    Jul 12, 2021

    Dyslipidemia Trial in United States (AZD8233 subcutaneous injection, Placebo)

    Completed
    • Dyslipidemia
    • AZD8233 subcutaneous injection
    • Placebo
    • Chula Vista, California
    • +6 more
    Jun 29, 2021

    Hyperlipidemia, Dyslipidemia Trial in United States (NK-104-CR, Livalo® IR, Placebo (for NK-104-CR))

    Withdrawn
    • Hyperlipidemia
    • Dyslipidemia
    • Foley, Alabama
    • +68 more
    May 6, 2021

    Hyperlipidemia, Dyslipidemia Trial in United States (NK-104-CR, Placebo, Livalo)

    Withdrawn
    • Hyperlipidemia
    • Dyslipidemia
    • Beverly Hills, California
    • +44 more
    May 6, 2021

    Hypertension, Dyslipidemia Trial in Seoul (Duowell®, Telmisartan)

    Completed
    • Hypertension
    • Dyslipidemia
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Apr 4, 2021

    Dyslipidemia Trial in United States (ETC-1002, Placebo)

    Completed
    Has Results
    • Dyslipidemia
    • Chandler, Arizona
    • +10 more
    Mar 15, 2021

    Hypertension, Dyslipidemia Trial (Valsartan 160mg + Rosuvastatin 20mg, Valsartan 320mg + Rosuvastatin 20mg, Diovan® 160mg +

    Withdrawn
    • Hypertension
    • Dyslipidemia
    • Valsartan 160mg + Rosuvastatin 20mg
    • +3 more
    • (no location specified)
    Feb 23, 2021

    Cardiovascular Events Based On Statin Initiation In The Elderly

    Completed
    Has Results
    • Cardiovascular
    • Dyslipidemia
    • Atorvastatin Initiators
    • Simvastatin Initiators
    • (no location specified)
    Feb 17, 2021

    Statin Treatment Of Patients With High Blood Cholesterol Levels

    Completed
    Has Results
    • Dyslipidemia
    • Patient Compliance
    • Mecidiyekoy, Istanbul, Turkey
    • +4 more
    Feb 17, 2021

    Africa and Middle East Cardiovascular Epidemiological Study

    Completed
    • Obesity
    • +4 more
      • Alger, Algeria
      • +73 more
      Feb 17, 2021

      Coronary Arteriosclerosis, Diabetes, Type 2, Cerebrovascular Accident Trial in Worldwide (Atorvastatin (Lipitor))

      Completed
      • Coronary Arteriosclerosis
      • +4 more
      • Atorvastatin (Lipitor)
      • Ioannina, Greece
      • +32 more
      Feb 17, 2021

      Coronary Arteriosclerosis, Diabetes, Type 2, Cerebrovascular Accident Trial in Worldwide (Atorvastatin (Lipitor))

      Completed
      • Coronary Arteriosclerosis
      • +4 more
      • Atorvastatin (Lipitor)
      • Mississauga, Ontario, Cameroon
      • +120 more
      Feb 17, 2021

      Dyslipidemia Trial in Malaysia (COACH, No intervention for )

      Completed
      • Dyslipidemia
      • COACH
      • No intervention for placebo
      • Jitra, Kubang Pasu, Kedah, Malaysia
      • +21 more
      Feb 17, 2021

      Diabetes Type 2, Dyslipidemia, Non-alcoholic Fatty Liver Disease Trial in Stockholm (Low calorie diet followed by life style

      Enrolling by invitation
      • Diabetes Mellitus Type 2
      • +3 more
      • Low calorie diet followed by life style intervention
      • Stockholm, Sweden
        Karolinska University Hospital
      Feb 17, 2021

      Dyslipidemia, Hypertension Trial in United States (Amlodipine besylate, Amlodipine besylate/atorvastatin calcium single pill

      Completed
      Has Results
      • Dyslipidemia
      • Hypertension
      • Amlodipine besylate
      • Amlodipine besylate/atorvastatin calcium single pill combination
      • Birmingham, Alabama
      • +50 more
      Jan 26, 2021

      Hypertension, Dyslipidemia Trial in United States (Caduet)

      Completed
      • Hypertension
      • Dyslipidemia
      • Jonesboro, Arkansas
      • +33 more
      Jan 26, 2021

      Hypertension, Dyslipidemia Trial in Canada, United Kingdom (Amlodipine/Atorvastatin)

      Completed
      • Hypertension
      • Dyslipidemia
      • Calgary, Alberta, Canada
      • +125 more
      Jan 26, 2021